The results in vitro and in vivo show that the FSTL5 inhibit HCC growth by promoting caspase‐dependent apoptosis of HCC cells and regulating Bcl‐2 family proteins in HCC, rather than influencing cell cycle. The gene discussed is FSTL5; the disease is hepatocellular carcinoma.